The DOI matches its Crossref record; 110 of the 110 references it cites were found in a registry or an index.
Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
Ge, D., Fellay, J., Thompson, A. J., Simon, J. S., Shianna, K. V., Urban, T. J., Heinzen, E. L., Qiu, P., Bertelsen, A. H., Muir, A. J., et al. (2009) · Nature · doi:10.1038/nature08309 · Cited by 3,514
A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis
Giovannoni, G., Comi, G., Cook, S., Rammohan, K., Rieckmann, P., Sørensen, P. S., Vermersch, P., Chang, P., Hamlett, A., Musch, B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0902533 · Cited by 1,023
Nucleotide Polymerase Inhibitor Sofosbuvir plus Ribavirin for Hepatitis C
Gane, E. J., Stedman, C. A., Hyland, R. H., Ding, X., Svarovskaia, E., Symonds, W. T., Hindes, R. G., & Berrey, M. M. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1208953 · Cited by 764
Pharmacogenomics and Individualized Drug Therapy
Eichelbaum, M., Ingelman-Sundberg, M., & Evans, W. E. (2006) · Annual Review of Medicine · doi:10.1146/annurev.med.56.082103.104724 · Cited by 720
Hepatitis B Virus Resistance to Nucleos(t)ide Analogues
Zoulim, F., & Locarnini, S. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.08.063 · Cited by 706
Self-citationAcyclic nucleoside phosphonates: a key class of antiviral drugs
Clercq, E. D., & Holý, A. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1877 · Cited by 688
Inhibition of DNA Methylation and Reactivation of Silenced Genes by Zebularine
Cheng, J. C., Matsen, C. B., Gonzales, F. A., Ye, W., Greer, S., Marquez, V. E., Jones, P. A., & Selker, E. U. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.5.399 · Cited by 535
Spratlin, J., Sangha, R., Glubrecht, D., Dabbagh, L., Young, J. D., Dumontet, C., Cass, C., Lai, R., & Mackey, J. R. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0224 · Cited by 430
Self-citationRichman, D. D. (2001) · Nature · doi:10.1038/35073673 · Cited by 419
Lee, W. A., He, G.-X., Eisenberg, E., Cihlar, T., Swaminathan, S., Mulato, A., & Cundy, K. C. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.5.1898-1906.2005 · Cited by 338
Gane, E. J., Roberts, S. K., Stedman, C. A., Angus, P. W., Ritchie, B., Elston, R., Ipe, D., Morcos, P. N., Baher, L., Najera, I., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61384-0 · Cited by 335
Yoshino, T., Mizunuma, N., Yamazaki, K., Nishina, T., Komatsu, Y., Baba, H., Tsuji, A., Yamaguchi, K., Muro, K., Sugimoto, N., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70345-5 · Cited by 326
HIV-1 Antiretroviral Resistance: Scientific Principles and Clinical Applications
Tang, M. W., & Shafer, R. W. (2012) · Drugs · doi:10.2165/11633630-000000000-00000 · Cited by 326
Feldman, E. J., Lancet, J. E., Kolitz, J. E., Ritchie, E. K., Roboz, G. J., List, A. F., Allen, S. L., Asatiani, E., Mayer, L. D., Swenson, C., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.5961 · Cited by 310
Pronucleotides: Toward thein vivo delivery of antiviral and anticancer nucleotides
Wagner, C. R., Iyer, V. V., & McIntee, E. J. (2000) · Medicinal Research Reviews · doi:10.1002/1098-1128(200011)20:6<417::aid-med1>3.0.co;2-z · Cited by 265
Immordino, M. L., Brusa, P., Rocco, F., Arpicco, S., Ceruti, M., & Cattel, L. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.09.001 · Cited by 251
Nucleoside analogs: molecular mechanisms signaling cell death
Ewald, B., Sampath, D., & Plunkett, W. (2008) · Oncogene · doi:10.1038/onc.2008.316 · Cited by 247
Maréchal, R., Bachet, J., Mackey, J. R., Dalban, C., Demetter, P., Graham, K., Couvelard, A., Svrcek, M., Bardier–Dupas, A., Hammel, P., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.06.006 · Cited by 241
Self-citationDelivery of 5-Aza-2′-Deoxycytidine to Cells Using Oligodeoxynucleotides
Yoo, C. B., Jeong, S., Egger, G., Liang, G., Phiasivongsa, P., Tang, C., Redkar, S., & Jones, P. A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0251 · Cited by 219
Maréchal, R., Mackey, J. R., Lai, R., Demetter, P., Peeters, M., Polus, M., Cass, C. E., Young, J., Salmon, I., Devière, J., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2080 · Cited by 219
García-Manteiga, J. M., Molina‐Arcas, M., Casado, F. J., Mazo, A., & Pastor‐Anglada, M. (2003) · PubMed · Cited by 211
Painter, W., Robertson, A. T., Trost, L. C., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05983-11 · Cited by 177
Erion, M. D., Reddy, K. R., Boyer, S. H., Matelich, M. C., Gomez-Galeno, J., Lemus, R. H., Ugarkar, B. G., Colby, T. J., Schanzer, J., & van Poelje, P. D. (2004) · Journal of the American Chemical Society · doi:10.1021/ja031818y · Cited by 165
The ribonucleotide reductase large subunit (RRM1) as a predictive factor in patients with cancer
Jordheim, L. P., Sève, P., Trédan, O., & Dumontet, C. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70244-8 · Cited by 164
Self-citationChuang, J. C., Warner, S. L., Vollmer, D. L., Vankayalapati, H., Redkar, S., Bearss, D. J., Qiu, X., Yoo, C. B., & Jones, P. A. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-1048 · Cited by 164
Antibacterial activity and mechanism of action of 3'-azido-3'-deoxythymidine (BW A509U)
Elwell, L. P., Ferone, R., Freeman, G. A., Fyfe, J. A., Hill, J. A., Ray, P. H., Richards, C. A., Singer, S. C., Knick, V. B., & Rideout, J. L. (1987) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.31.2.274 · Cited by 160
Antitumoral activity of PEG–gemcitabine prodrugs targeted by folic acid
Pasut, G., Canal, F., Dalla Via, L., Arpicco, S., Veronese, F. M., & Schiavon, O. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.02.002 · Cited by 160
A 40-Year Journey in Search of Selective Antiviral Chemotherapy*
De Clercq, E. (2011) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010510-100228 · Cited by 159
Solmone, M., Vincenti, D., Prosperi, M. C. F., Bruselles, A., Ippolito, G., & Capobianchi, M. R. (2009) · Journal of Virology · doi:10.1128/jvi.02011-08 · Cited by 158
Vignuzzi, M., Stone, J. K., & Andino, R. (2004) · Virus Research · doi:10.1016/j.virusres.2004.11.007 · Cited by 154
The HIVdb System for HIV-1 Genotypic Resistance Interpretation
Tang, M. W., Liu, T. F., & Shafer, R. W. (2012) · Intervirology · doi:10.1159/000331998 · Cited by 153
McGinn, C. J., Shewach, D. S., & Lawrence, T. S. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.17.1193 · Cited by 148
17th conference on retroviruses and opportunistic infections
松下, 修. (2010) · HIV感染症とAIDSの治療 · Cited by 144
Molecular strategies to inhibit the replication of RNA viruses
Leyssen, P., Clercq, E. D., & Neyts, J. H. (2008) · Antiviral Research · doi:10.1016/j.antiviral.2008.01.004 · Cited by 140
Ciccolini, J., Dahan, L., André, N., Evrard, A., Duluc, M., Blesius, A., Yang, C., Giacometti, S., Brunet, C., Raynal, C., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.4491 · Cited by 136
Couvreur, P., Reddy, L. H., Mangenot, S., Poupaert, J. H., Desmaële, D., Lepêtre‐Mouelhi, S., Pili, B., Bourgaux, C., Amenitsch, H. W., & Ollivon, M. (2008) · Small · doi:10.1002/smll.200700731 · Cited by 131
Rosell, R., Felip, E., Tarón, M., Majo, J., Méndez, P., Sanchez-Ronco, M., Queralt, C., Sánchez, J. J., & Maestre, J. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-040006 · Cited by 128
Calvagno, M. G., Celia, C., Paolino, D., Cosco, D., Iannone, M., Castelli, F., Doldo, P., & Fresta, M. (2006) · Current Drug Delivery · doi:10.2174/156720107779314749 · Cited by 124
Ford, L. T., & Berg, J. D. (2010) · Journal of Clinical Pathology · doi:10.1136/jcp.2009.069252 · Cited by 122
Liver-Targeted Drug Delivery Using HepDirect Prodrugs
Erion, M. D., van Poelje, P. D., MacKenna, D. A., Colby, T. J., Montag, A. C., Fujitaki, J. M., Linemeyer, D. L., & Bullough, D. A. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.075903 · Cited by 119
Lin, T., Luo, M., Liu, M., Zhu, Y.-L., Gullen, E. A., Dutschman, G. E., & Cheng, Y. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm950836q · Cited by 118
Babusis, D. M., Phan, T. K., Lee, W. A., Watkins, W. J., & Ray, A. S. (2012) · Molecular Pharmaceutics · doi:10.1021/mp3002045 · Cited by 111
Synthesis, Crystallization, and Biological Evaluation of an Orally Active Prodrug of Gemcitabine
Bender, D. M., Bao, J., Dantzig, A. H., Diseroad, W. D., Law, K. L., Magnus, N. A., Peterson, J. A., Perkins, E. J., Pu, Y. J., Reutzel‐Edens, S. M., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901181h · Cited by 107
A novel antimetabolite, TAS-102 retains its effect on FU-related resistant cancer cells
Emura, T., Murakami, Y., Nakagawa, F., Fukushima, M., & Kitazato, K. (2004) · International Journal of Molecular Medicine · doi:10.3892/ijmm.13.4.545 · Cited by 104
Pratt, S. E., Durland–Busbice, S., Shepard, R. L., Heinz-Taheny, K. M., Iversen, P. W., & Dantzig, A. H. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1184 · Cited by 104
Réjiba, S., Reddy, L. H., Bigand, C., Parmentier, C., Couvreur, P., & Hajri, A. (2011) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2011.02.012 · Cited by 103
Zebularine: A Unique Molecule for an Epigenetically Based Strategy in Cancer Chemotherapy
Márquez, V. E., Kelley, J. A., Agbaria, R., BEN‐KASUS, T., Cheng, J., Yoo, C. B., & Jones, P. A. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1359.037 · Cited by 100
Bildstein, L., Dubernet, C., Marsaud, V., Chacun, H., Nicolas, V., Gueutin, C., Sarasin, A. R., Bénech, H., Lepêtre‐Mouelhi, S., Desmaële, D., et al. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.07.120 · Cited by 97
Clouser, C. L., Chauhan, J., Bess, M. A., van Oploo, J. L., Zhou, D., Dimick-Gray, S., Mansky, L. M., & Patterson, S. E. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.08.108 · Cited by 97
Bergman, A. M., Adema, A. D., Balzarini, J. M., Bruheim, S., Fichtner, I., Noordhuis, P., Fodstad, Ø., Myhren, F., Sandvold, M. L., Hendriks, H. R., et al. (2010) · Investigational New Drugs · doi:10.1007/s10637-009-9377-7 · Cited by 96
Ben-Kasus, T., Ben‐Zvi, Z., Márquez, V. E., Kelley, J. A., & Agbaria, R. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.04.010 · Cited by 94
Review of recent studies on resistance to cytotoxic deoxynucleoside analogues
Jordheim, L. P., & Dumontet, C. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2007.07.004 · Cited by 92
Self-citationBrueckner, B., Rius, M., Markelova, M. R., Fichtner, I., Hals, P., Sandvold, M. L., & Lyko, F. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-1202 · Cited by 92
Galmarini, C. M., Graham, K., Thomas, X., Calvo, F. M., Rousselot, P. H., Jafaari, A. E., Cros‐Perrial, E., Mackey, J. R., & Dumontet, C. (2001) · Blood · doi:10.1182/blood.v98.6.1922 · Cited by 89
Self-citationTatlisumak, T., Takano, K., Carano, R. A. D., Miller, L. P., Foster, A. C., & Fisher, M. (1998) · Stroke · doi:10.1161/01.str.29.9.1952 · Cited by 87
Analysis of Ribavirin Mutagenicity in Human Hepatitis C Virus Infection
Chevaliez, S., Brillet, R., Lázaro, E., Hézode, C., & Pawlotsky, J. (2007) · Journal of Virology · doi:10.1128/jvi.00382-07 · Cited by 85
Bergman, A. M., Kuiper, C. M., Voorn, D. A., Comijn, E. M., Myhren, F., Sandvold, M. L., Hendriks, H. R., & Peters, G. J. (2003) · Biochemical Pharmacology · doi:10.1016/j.bcp.2003.09.028 · Cited by 85
Vernachio, J. H., Bleiman, B., Bryant, K. D., Chamberlain, S. D., Hunley, D., Hutchins, J. T., Ames, B., Gorovits, E., Ganguly, B., Hall, A. E., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01335-10 · Cited by 84
DNA containing 4'-thio-2'-deoxycytidine inhibits methylation by HhaI methyltransferase
Kumar, S., Horton, J. R., Jones, G. D., Walker, R. T., Roberts, R. J., & Cheng, X. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.14.2773 · Cited by 81
Kantarjian, H. M., Garcia‐Manero, G., O'Brien, S. M., Faderl, S. H., Ravandi, F., Westwood, R., Green, S. R., Chiao, J. H., Boone, P. A., Cortes, J. E., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.0209 · Cited by 80
Drug uptake transporters in antiretroviral therapy
Minuesa, G., Huber‐Ruano, I., Pastor‐Anglada, M., Koepsell, H., Clotet, B., & Martínez‐Picado, J. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.06.007 · Cited by 79
Polyisoprenoyl gemcitabine conjugates self assemble as nanoparticles, useful for cancer therapy
Maksimenko, A., Mougin, J., Mura, S., Śliwiński, É., Lepeltier, É., Bourgaux, C., Lepêtre‐Mouelhi, S., Zouhiri, F., Desmaële, D., & Couvreur, P. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.08.023 · Cited by 79
Integrating pharmacogenetics into gemcitabine dosing—time for a change?
Ciccolini, J., Mercier, C., Dahan, L., & André, N. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2011.1 · Cited by 79
Henipavirus outbreaks to antivirals: the current status of potential therapeutics
Broder, C. C. (2012) · Current Opinion in Virology · doi:10.1016/j.coviro.2012.02.016 · Cited by 78
Reddy, L. H., Renoir, J., Marsaud, V., Lepêtre‐Mouelhi, S., Desmaële, D., & Couvreur, P. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900099e · Cited by 74
Guerhier, F. L., Pichoud, C., Guérret, S., Chevallier, M., Jamard, C., Hantz, O., Li, X., Chen, S., King, I., TREPO, C. G., et al. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.1.111-122.2000 · Cited by 72
Self-citationBreistøl, K., Balzarini, J. M., Sandvold, M. L., Myhren, F., Martinsen, M., Clercq, E. D., & Fodstad, Ø. (1999) · PubMed · Cited by 70
Antitumor activity and pharmacokinetics of liposomes containing lipophilic gemcitabine prodrugs.
Brusa, P., Immordino, M. L., Rocco, F., & Cattel, L. (2007) · PubMed · Cited by 68
Maréchal, R., Mackey, J. R., Lai, R. L., Demetter, P., Peeters, M., Polus, M., Cass, C. E., Salmon, I. J., Deviere, J. M. E., & Laethem, J. V. (2010) · Cancer · doi:10.1002/cncr.25303 · Cited by 67
Massively parallel pyrosequencing in HIV research
Bushman, F. D., Hoffmann, C., Ronen, K., Malani, N., Minkah, N. K., Rose, H. M., Tebas, P., & Wang, G. P. (2008) · AIDS · doi:10.1097/qad.0b013e3282fc972e · Cited by 67
Highlights in Antiviral Drug Research: Antivirals at the Horizon
Clercq, E. D. (2012) · Medicinal Research Reviews · doi:10.1002/med.21256 · Cited by 65
Role of Human Nucleoside Transporters in the Uptake and Cytotoxicity of Azacitidine and Decitabine
Damaraju, V. L., Mowles, D., Yao, S. Y. M., Ng, A. M. L., Young, J. D., Cass, C. E., & Tong, Z. (2012) · Nucleosides Nucleotides & Nucleic Acids · doi:10.1080/15257770.2011.652330 · Cited by 65
Characterization of a Gemcitabine-Resistant Murine Leukemic Cell Line
Jordheim, L. P., Cros‐Perrial, E., Gouy, M.-H., Galmarini, C. M., Peyrottes, S., Mackey, J. R., Périgaud, C., & Dumontet, C. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0506 · Cited by 65
Self-citationGökbuget, N., Hartog, C.-M., Bassan, R., Hg, D., Dombret, H., Greil, R., Hernández‐Rivas, J. M., Huguet, F., Intermesoli, T., Jourdan, É., et al. (2010) · Haematologica · doi:10.3324/haematol.2010.028092 · Cited by 65
Chung, W.-G., Sandoval, M. A., Sloat, B. R., Lansakara-P, D. S. P., & Cui, Z. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.08.004 · Cited by 60
Superior Preclinical Efficacy of Gemcitabine Developed As Chitosan Nanoparticulate System
Arias, J. L., Reddy, L. H., & Couvreur, P. (2010) · Biomacromolecules · doi:10.1021/bm101044h · Cited by 60
Celia, C., Cosco, D., Paolino, D., & Fresta, M. (2011) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2011.632630 · Cited by 57
de Beaumais, T. A., & Jacqz-Aigrain, É. (2012) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-012-1251-4 · Cited by 53
Doléans-Jordheim, A., Bergeron, E., Bereyziat, F., et al. (2011) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-011-1220-3 · Cited by 53
Metabolism and accumulation of the lipophilic deoxynucleoside analogs elacytarabine and CP-4126
Adema, A. D., Smid, K., Losekoot, N., Honeywell, R. J., Verheul, H. M. W., Myhren, F., Sandvold, M. L., & Peters, G. J. (2011) · Investigational New Drugs · doi:10.1007/s10637-011-9756-8 · Cited by 52
Radhakrishnan, S. K., & Gartel, A. L. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3940 · Cited by 52
Koolen, S. L. W., Witteveen, P. O., Jansen, R. S., Langenberg, M. H. G., Kronemeijer, R. H., Nol, A., Garcia‐Ribas, I., Callies, S., Benhadji, K. A., Slapak, C. A., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0353 · Cited by 51
Guerhier, F. L., Pichoud, C., Jamard, C., et al. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.4.1065-1077.2001 · Cited by 47
Lalezari, J. P., Lawitz, E., Rodriguez‐Torres, M., Sheikh, A. M., Freilich, B. L., Nelson, D. R., Hassanein, T., Mader, M., Albanis, E., Symonds, W. T., et al. (2011) · Journal of Hepatology · doi:10.1016/s0168-8278(11)60063-9 · Cited by 47
Nitanda, T., Wang, X., Kumamoto, H., Haraguchi, K., Tanaka, H., Cheng, Y., & Baba, M. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3355-3360.2005 · Cited by 47
Lanier, E. R., Ptak, R. G., Lampert, B. M., Keilholz, L., Hartman, T. L., Buckheit, R. W., Mankowski, M. K., Osterling, M. C., Almond, M. R., & Painter, G. R. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00068-10 · Cited by 46
Synthesis and Biological Evaluation of a Cytarabine Phosphoramidate Prodrug
Tobias, S. C., & Borch, R. F. (2003) · Molecular Pharmaceutics · doi:10.1021/mp034019v · Cited by 45
Multiple Myeloma Cell Killing by Depletion of the MET Receptor Tyrosine Kinase
Stellrecht, C. M., Phillip, C. J., Cervantes-Gomez, F., & Gandhi, V. V. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0770 · Cited by 43
Trifluorothymidine exhibits potent antitumor activity via the induction of DNA double-strand breaks
SUZUKI, N., Nakagawa, F., Nukatsuka, M., & Fukushima, M. (2011) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2011.244 · Cited by 39
CP‐4055 and CP‐4126 are active in ara‐C and gemcitabine‐resistant lymphoma cell lines
Galmarini, C. M., Myhren, F., & Sandvold, M. L. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07467.x · Cited by 39
Bethell, R. C., Lie, Y., & Parkin, N. T. (2005) · Antiviral chemistry & chemotherapy · doi:10.1177/095632020501600502 · Cited by 38
Paolino, D., Cosco, D., Rocco, Ceruti, Vono, & Fresta, M. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s28114 · Cited by 37
Pentikis, H. S., Matson, M., Atiee, G. J., Boehlecke, B. A., Hutchins, J. T., Patti, J. M., Henson, G. W., & Morris, A. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01446-10 · Cited by 37
Jordheim, L. P., Larbi, S. B., Fendrich, O., Ducrot, C., Bergeron, E., Dumontet, C., Freney, J., & Doléans-Jordheim, A. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2012.01.019 · Cited by 36
Self-citationGeutjes, E.-J., Tian, S., Roepman, P., & Bernards, R. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1477-3 · Cited by 33
Stellrecht, C. M., Ayres, M., Arya, R., & Gandhi, V. V. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0481-3 · Cited by 30
Preclinical antitumor activity of 4′-thio-β-d-arabinofuranosylcytosine (4′-thio-ara-C)
Waud, W. R., Gilbert, K. S., Shepherd, R. V., Montgomery, J. A. J., & Secrist, J. A. I. (2003) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-003-0589-9 · Cited by 28
8-Amino-Adenosine Inhibits Multiple Mechanisms of Transcription
Frey, J. A., & Gandhi, V. V. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0767 · Cited by 28
Gu, Y., Zhang, H., Zhang, H., Li, S., Ni, J., & Jia, H. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.05.026 · Cited by 27
Sharma, N. K., Mahadevan, N., & Balakumar, P. (2012) · Cardiovascular Toxicology · doi:10.1007/s12012-012-9182-y · Cited by 26
Elion, G. B. (1993) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.33.040193.000245 · Cited by 25
El-Mabhouh, A. A., Nation, P. N., Abele, J. T., et al. (2011) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504011x13021877989874 · Cited by 23
Analysis of the Ex Vivo and In Vivo Antiretroviral Activity of Gemcitabine
Clouser, C. L., Holtz, C. M., Mullett, M. A., Crankshaw, D. L., Briggs, J. E., Chauhan, J., Matise, I., Patterson, S. E., & Mansky, L. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0015840 · Cited by 23
Yoo, C. B., Valente, R., Congiatu, C., Gavazza, F., Angel, A., Siddiqui, M. A., Jones, P. A., McGuigan, C., & Márquez, V. E. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8005965 · Cited by 22
Gilbert, J., Carducci, M. A., Baker, S. D., Dees, E. C., & Donehower, R. C. (2006) · Investigational New Drugs · doi:10.1007/s10637-006-8219-0 · Cited by 20
Delaunoit, T., Burch, P. A., Reid, J. M., Camoriano, J. K., Kobayash, T., Braich, T. A., Kaur, J. S., Rubin, J., & Erlichman, C. (2006) · Investigational New Drugs · doi:10.1007/s10637-006-5392-0 · Cited by 18
Tsai, C., Ray, A. S., Tumas, D. B., Keating, M. J., Reiser, H., & Plunkett, W. K. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2848 · Cited by 15
Someya, H., Waud, W. R., & Parker, W. B. (2005) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-005-0126-0 · Cited by 14
Uckun, F. M., Cahn, P. E., Qazi, S., & D’Cruz, O. J. (2012) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2012.664635 · Cited by 10
Lee, C. P., de Jonge, M. J. A., O'Donnell, A. E., Schothorst, K. L., Hanwell, J., Chick, J., Brooimans, R. A., Adams, L. M., Drolet, D. W., Bono, J. S. D., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1932 · Cited by 8
Cited by
Cellular Senescence: Aging, Cancer, and Injury
Calcinotto, A., Kohli, J., Zagato, E., Pellegrini, L., Demaria, M., & Alimonti, A. (2019) · Physiological Reviews · doi:10.1152/physrev.00020.2018 · Cited by 1,270
Regulation of mammalian nucleotide metabolism and biosynthesis
Lane, A. N., & Fan, T. W.-M. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv047 · Cited by 959
Eastman, R. T., Roth, J. S., Brimacombe, K. R., Simeonov, A., Shen, M., Patnaik, S., & Hall, M. D. (2020) · ACS Central Science · doi:10.1021/acscentsci.0c00489 · Cited by 953
Wang, H.-X., Li, M., Lee, C. M., Chakraborty, S., Kim, H.-W., Bao, G., & Leong, K. W. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00799 · Cited by 560
Seley-Radtke, K. L., & Yates, M. K. (2018) · Antiviral Research · doi:10.1016/j.antiviral.2018.04.004 · Cited by 543
Metadata
- Authors
- Jordheim, L. P., Durantel, D., Zoulim, F., & Dumontet, C.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2013-05-31
- Volume
- 12
- Issue
- 6
- Pages
- 447-464
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2147458973
- Cited by
- 1,211
- References
- 110
- FWCI
- 9.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.